Buhai Wang
ORCID：0000-0001-6391-4502
发表论文 94 篇 · 总被引 6677 次 · h-index 22
代表论文
- Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial (2023 · British Journal of Cancer · 被引 23)
- Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer (2024 · Cancer Cell · 被引 22)
- Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial (2026 · The Lancet · 被引 20)
- Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy (2024 · Journal of Controlled Release · 被引 19)
- Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 16)
- Sintilimab plus HPV vaccine for recurrent or metastatic cervical cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 12)